Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).
Intestinal worms could hold key to treating inflammatory bowel disease
A four year-long research study has found that particles secreted by an intestinal worm may assist in treating inflammatory ...
Inflammatory bowel disease tied to higher risk for heart disease
Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a ...
Eight ways to reduce your risk of bowel cancer
Eight ways to reduce your risk of bowel cancer - Around half of all bowel cancers could be prevented by having a healthier ...
New bowel cancer test has ‘90% accuracy’ at predicting disease in those at high risk – without invasive procedures
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
Exploring irritable bowel syndrome: A common disorder with complex gut-brain interactions
Bowel movements, bloating, and other digestive issues may not be the easiest topics to discuss with your doctor, but having a ...
The Lancet2d
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...
Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
Meet the dogs being trained to sniff out early stage bowel cancer
Cocker Spaniels Mango, Callie and Dotty, Labradors Hetty, Rosie and Jodie, and Flat-coated Retriever Willow are showing real ...
Bowel cancer prediction test for IBD patients 90% accurate
A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the ...
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying active inflammation in individuals with Crohn's disease. Credit: ...
Pharmabiz2d
Jaguar Health begins patient dosing in short bowel syndrome with intestinal failure in investigator-initiated trial of crofelemer
San Francisco, California Wednesday, February 5, 2025, 16:00 Hrs [IST] ...